[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100553510":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":27,"responsibleParty":67,"collaborators":20,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":20,"eligibilityCriteria":75,"healthyVolunteers":71,"sex":76,"minAge":77,"maxAge":20,"enrollmentInfo":78,"targetDuration":20,"studyType":81,"phases":82,"briefSummary":84,"conditions":85,"keywords":20,"overallStatus":87,"whyStopped":20,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"EpiSonica","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"MRgHIFU treatment arm","EXPERIMENTAL","Subjects will receive MRgHIFU treatment by using ArcBlate Focused Ultrasound Ablation System.",[13],"Device: ArcBlate Focused Ultrasound Ablation System",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","ArcBlate Focused Ultrasound Ablation System","MR-guided High Intensity Focused Ultrasound (MRgHIFU)",[9],null,[22],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Feng-Xian Yan","CONTACT","+886-3-5712354","angelay@episonica.com",[28,40,49,58],{"facility":29,"status":20,"city":30,"state":20,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":20},"Far Eastern Memorial Hospital","New Taipei City","220","Taiwan","TW",{"type":35,"coordinates":36},"Point",[37,38],121.45703,25.06199,{"lat":38,"lon":37},{"facility":41,"status":20,"city":42,"state":20,"zip":43,"country":32,"countryCode":33,"cosmosGeoPoint":44,"geoPoint":48,"contacts":20},"Taichung Veterans General Hospital","Taichung","407",{"type":35,"coordinates":45},[46,47],120.6839,24.1469,{"lat":47,"lon":46},{"facility":50,"status":20,"city":51,"state":20,"zip":52,"country":32,"countryCode":33,"cosmosGeoPoint":53,"geoPoint":57,"contacts":20},"National Taiwan University Hospital","Taipei","100",{"type":35,"coordinates":54},[55,56],121.52639,25.05306,{"lat":56,"lon":55},{"facility":59,"status":20,"city":60,"state":20,"zip":61,"country":32,"countryCode":33,"cosmosGeoPoint":62,"geoPoint":66,"contacts":20},"Chang Gung Memorial Hospital - Linkou","Taoyuan","333",{"type":35,"coordinates":63},[64,65],121.29696,24.99368,{"lat":65,"lon":64},{"type":68,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100553510","safety-of-arcblate-mrghifu-in-patients-with-painful-bone-metastases-an-extension-study-100553510",false,"NCT06487026","Safety of ArcBlate MRgHIFU in Patients With Painful Bone Metastases: An Extension Study","An Extension Study to Evaluate the Safety of ArcBlate MRgHIFU in Patients With Painful Bone Metastases","Inclusion Criteria:\n\n1. Male or female, who randomized into Sham control group and withdrew from CTP-BM-22-01 Study (i.e. main study) due to lack of efficacy.\n2. Completed 14-day evaluation in main study.\n3. Will provide completed and signed written informed consents.\n\nExclusion Criteria:\n\n1. Pregnant women.\n2. Subjects who do not meet any of the inclusion criteria in CTP-BM-22-01 Study (i.e. main study) after re-evaluation.\n3. Determined by the investigator to be not suitable for the conduct of the study for any other reasons.","ALL","18 Years",{"count":79,"type":80},25,"ESTIMATED","INTERVENTIONAL",[83],"NA","An Extension Study to Evaluate the Safety of ArcBlate MRgHIFU in Patients with Painful Bone Metastases",[86],"Bone Metastases","NOT_YET_RECRUITING","2024-06-27",{"date":90,"type":91},"2024-07-05","ACTUAL",{"date":93,"type":80},"2024-08-01",{"date":95,"type":80},"2025-10-31",{"name":5,"class":6},4]